La Jolla Pharmaceutical Company

MA · United States · Reporting entity ID 100000231830

Total reported 2019–2025

$5.96M

#651 of 2,960 reporting companies — 0% of all reported industry payments

$3.16M in general payments across 18,786 records, plus $2.80M in research funding across 309 records.

How it breaks down

General payments $3,160,408

Research funding $2,797,988

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.